The South Korea acne vulgaris therapeutics market size stood at around USD xx billion in 2019 and is projected to reach xx billion by 2028, exhibiting a CAGR of around 2.8% during the forecast period.
Acne vulgaris is the formation of comedones, papules, pustules, nodules, and/or cysts. It occurs through the interplay of 4 major factors: excess sebum production, follicular plugging with sebum and keratinocytes, colonization of follicles by Cutibacterium acnes, a normal human anaerobe and release of multiple inflammatory mediators. It develops on the face and upper trunk.
Acne is prevalent among the adolescents of South Korea and their population has grown by 0.09% in 2020 according to the World Population Review. Acne Vulgaris is one of the most common skin disorders which dermatologists have to treat.
South Korea Acne Vulgaris Market is driven by rising prevalence of acne and the growing teenage population. 85% of teenagers get acne, according to UC Davis Health. In addition, millennials actually make up 22.2% of the South Korean population, according to the Korean Statistics Bureau (KOSTAT), thus providing considerable growth prospect for the industry. Unhealthy eating habits, lifestyle changes and rising pollution further increase the number of acne cases, which in turn is expected to fuel revenues in acne treatment market.
The psychological burden associated with acne is high. Patients suffering from acne face depression and other related issues. This creates immediate increase in the demand for acne treatments.